REDMILE GROUP, LLC – Nurix Therapeutics, Inc. Transaction History
REDMILE GROUP, LLC portfolio value:
$39.17M
portfolio value
REDMILE GROUP, LLC quarter portfolio value change:
+2.84%
quarter
Nurix Therapeutics, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | 0.00% | 0 shares | 1.08M | $13.03 | 3.00M | |
| Q2 2022 | share | Decrease | -0.40% | -12.1K shares | -4.19M | $12.67 | 3.00M |
| Q1 2022 | share | Increase | +2.05% | 60.5K shares | -43.34M | $14.01 | 3.01M |
| Q4 2021 | share | Decrease | -4.36% | -134.79K shares | -7.02M | $29.98 | 2.95M |
| Q3 2021 | share | Decrease | -3.04% | -97K shares | 8.03M | $29.96 | 3.09M |
| Q2 2021 | share | Decrease | -3.74% | -124.04K shares | -18.40M | $26.53 | 3.19M |
| Q1 2021 | share | Increase | +16.44% | 467.99K shares | 9.45M | $31.09 | 3.31M |
| Q4 2020 | share | Increase | +9.74% | 252.55K shares | 3.03M | $32.88 | 2.84M |
| Q3 2020 | share | Increase | 0.00% | 2.59M shares | 90.54M | $34.91 | 2.59M |